Skip to main content

MW 624.66 g/mol, Purity >98%. Potent, dual PI3Kα/mTOR inhibitor (IC50 values are 0.9 and 0.6 nM at PI3Kα and mTOR, respectively). Inhibits tumor cell growth, suppresses phosphorylation of downstream targets of PI3Kα and mTOR in vitro and promotes tumor regression in vivo..

Be the first to review this product! Submit a review

Images

Chemical Structure - CAY10626, PI3Kalpha/mTOR inhibitor (AB120903), expandable thumbnail
  • Functional Studies - CAY10626, PI3Kalpha/mTOR inhibitor (AB120903), expandable thumbnail

Key facts

CAS number
1202884-94-3
Purity
> 98%
Molecular weight
624.66 g/mol
Molecular formula
C31H35F3N8O3
Nature
Synthetic

Target data

Recommended products

MW 624.66 g/mol, Purity >98%. Potent, dual PI3Kα/mTOR inhibitor (IC50 values are 0.9 and 0.6 nM at PI3Kα and mTOR, respectively). Inhibits tumor cell growth, suppresses phosphorylation of downstream targets of PI3Kα and mTOR in vitro and promotes tumor regression in vivo..

Key facts

Purity
> 98%
Solubility

Soluble in DMSO to 10 mM.

Biological description

Potent, dual PI3Kα/mTOR inhibitor (IC50 values are 0.9 and 0.6 nM at PI3Kα and mTOR, respectively). Inhibits tumor cell growth, suppresses phosphorylation of downstream targets of PI3Kα and mTOR in vitro and promotes tumor regression in vivo.

Canonical SMILES
O=C(NC1=CC=C(C(N(C)CCN(C)C)=O)C=C1)NC2=CC=C(C3=NC(N4CCOCC4)=C(C=CN5CC(F)(F)F)C5=N3)C=C2
IUPAC name
N-[2-(Dimethylamino)ethyl]-N-methyl-4-[[[[4-[4-(4-morpholinyl)-7-(2,2,2-trifluoroethyl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl]phenyl]amino]carbonyl]amino]benzamide

Storage

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store under desiccating conditions, The product can be stored for up to 12 months

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

2 product images

  • Chemical Structure - CAY10626, PI3Kalpha/mTOR inhibitor (ab120903), expandable thumbnail

    Chemical Structure - CAY10626, PI3Kalpha/mTOR inhibitor (ab120903)

    2D chemical structure image of ab120903, CAY10626, PI3Kalpha/mTOR inhibitor

  • Functional Studies - CAY10626, PI3Kalpha/mTOR inhibitor (ab120903), expandable thumbnail

    Functional Studies - CAY10626, PI3Kalpha/mTOR inhibitor (ab120903)

    Anti-AKT1 (phospho S473) antibody [EP2109Y] ab81283 staining AKT1 (phospho S473) in PC3 cells treated with CAY10626 (ab120903), by ICC/IF. Decrease of AKT1 (phospho S473) expression correlates with increased concentration of CAY10626, as described in literature.
    The cells were incubated at 37°C for 24h in media containing different concentrations of ab120903 (CAY10626) in DMSO, fixed with 4% formaldehyde for 10 minutes at room temperature and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with Anti-AKT1 (phospho S473) antibody [EP2109Y] ab81283 (1/100) dilution was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight 488 anti-rabbit polyclonal antibody (Goat Anti-Rabbit IgG H&L (DyLight® 488) preadsorbed ab96899) at 1/250 dilution was used as the secondary antibody. Nuclei were counterstained with DAPI and are shown in blue.

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com